Prelude Therapeutics
- Pharmaceutical Preparations
- Wilmington, Delaware
Compensation history
Top executives at Prelude Therapeutics received an average of $3M per person in annual compensation from 2020 to 2023.
Average pay of disclosed executives at Prelude Therapeutics
By year
Executives
We found six executives who work or worked at Prelude Therapeutics.
Krishna Vaddi
Prelude Therapeutics
Chief Executive Officer
Jane Huang
Prelude Therapeutics
Chief Medical Officer
Bryant Lim
Prelude Therapeutics
Chief Financial Officer
Peggy Scherle
Prelude Therapeutics
Chief Scientific Officer
Andrew Combs
Prelude Therapeutics
EVP and Head of Chemistry
Brian Piper
Prelude Therapeutics
Chief Financial Officer
News
About Prelude Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address175 Innovation Boulevard, Wilmington, Delaware 19805
- Phone(302) 467-1280
- Fiscal year endDecember 31
- Former names
- Prelude Therapeutics Inc.Until October 19, 2017
Source: SEC filings on April 26, 2024, April 28, 2023, and April 29, 2022.